Halipa, Jaharia .

HRN: 18-69-41  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/09/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/09/2025
12/16/2025
IV
500mg
Q8
S/p Cs
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: